Om P. Sharma
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Om P. Sharma has a total of 4 co-authors. Here are the top co-authors by number of shared publications:
Violeta Vucinic
3 shared publicationsAlison G. Wilcox
1 shared publicationD G James
Royal Free Hospital, London, UK
1 shared publicationD Geraint James
1 shared publication
Latest Publications
- 1 October 2002
- Vol. 19 (3) , 227-33
Sarcoidosis of the upper respiratory tract. Selected cases emphasizing diagnostic and therapeutic difficulties.
Sarcoidosis of the upper respiratory tract (SURT) is a frequently overlooked and inadequately treated complication of sarcoidosis. The aim of this descriptive study is to present selected cases of sarcoidosis of the upper respiratory tract depicting diagnostic and therapeutic challenges. Five selected patients who either had an unusual initial presentation or an unusual clinical course were included if they also had long follow up. The diagnosis of SURT was based on the conventional criteria including histological evidence and appropriate microbiological studies. These case studies underline problems that may arise when SURT is not recognized early and appropriate and adequate treatment is delayed.
- 1 October 2002
- Vol. 19 (3) , 227-33
Sarcoidosis of the upper respiratory tract. Selected cases emphasizing diagnostic and therapeutic difficulties.
Sarcoidosis of the upper respiratory tract (SURT) is a frequently overlooked and inadequately treated complication of sarcoidosis. The aim of this descriptive study is to present selected cases of sarcoidosis of the upper respiratory tract depicting diagnostic and therapeutic challenges. Five selected patients who either had an unusual initial presentation or an unusual clinical course were included if they also had long follow up. The diagnosis of SURT was based on the conventional criteria including histological evidence and appropriate microbiological studies. These case studies underline problems that may arise when SURT is not recognized early and appropriate and adequate treatment is delayed.
- 7 September 2002
- Vol. 48 (2) , 135-41
Pulmonary sarcoidosis: management.
During the last two decades many advances have been made in the field of sarcoidosis. The disease is now recognised as a multisystem disorder occurring in patients with a genetic predisposition and an exposure to yet unknown transmissible environmental agent/s. The diagnosis is based on a compatible clinical and/or radiological picture, histological evidence of non-caseating granuloma and exclusion of other diseases capable of producing a similar clinical or histological picture. Treatment primarily consists of administration of corticosteroids, although there are valuable alternative drugs. Treatment should be considered in symptomatic patients with evidence of radiologic or lung function deterioration. The patients with extra-pulmonary involvement particularly with ocular, myocardial, and neuro-sarcoidosis almost always need treatment. For asymptomatic pulmonary sarcoidosis patients no therapy is needed.
- 7 September 2002
- Vol. 48 (2) , 135-41
Pulmonary sarcoidosis: management.
During the last two decades many advances have been made in the field of sarcoidosis. The disease is now recognised as a multisystem disorder occurring in patients with a genetic predisposition and an exposure to yet unknown transmissible environmental agent/s. The diagnosis is based on a compatible clinical and/or radiological picture, histological evidence of non-caseating granuloma and exclusion of other diseases capable of producing a similar clinical or histological picture. Treatment primarily consists of administration of corticosteroids, although there are valuable alternative drugs. Treatment should be considered in symptomatic patients with evidence of radiologic or lung function deterioration. The patients with extra-pulmonary involvement particularly with ocular, myocardial, and neuro-sarcoidosis almost always need treatment. For asymptomatic pulmonary sarcoidosis patients no therapy is needed.
- 1 September 2002
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 8 (5) , 452-456
Sarcoidosis and other autoimmune disorders
The relation between sarcoidosis and autoimmune disorders was first suggested by Telium about half a century ago. He noted that there were certain clinical and laboratory similarities between systemic lupus erythematosus and sarcoidosis and mused that the common features were hyperglobulinemia, “hyalinosis” in the reticuloendothelial system, epithelioid cell granulomas, and periarterial hyaline zones in the spleen. Now, the inclusion of sarcoidosis into the group of disorders of autoimmunity is a discarded notion. Sarcoidosis does not meet the criteria for autoimmune disease. Nevertheless, there are ample examples of coexistence of sarcoidosis and a wider range of autoimmune disorders.
- 1 September 2002
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 8 (5) , 452-456
Sarcoidosis and other autoimmune disorders
The relation between sarcoidosis and autoimmune disorders was first suggested by Telium about half a century ago. He noted that there were certain clinical and laboratory similarities between systemic lupus erythematosus and sarcoidosis and mused that the common features were hyperglobulinemia, “hyalinosis” in the reticuloendothelial system, epithelioid cell granulomas, and periarterial hyaline zones in the spleen. Now, the inclusion of sarcoidosis into the group of disorders of autoimmunity is a discarded notion. Sarcoidosis does not meet the criteria for autoimmune disease. Nevertheless, there are ample examples of coexistence of sarcoidosis and a wider range of autoimmune disorders.
- 1 June 2002
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 23 (2) , 329-339
Granulomatous lung diseases in the tropics
- 1 June 2002
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 23 (2) , 329-339
Granulomatous lung diseases in the tropics
- 1 March 2002
- Vol. 19 (1) , 66-70
Splenectomy in sarcoidosis: indications, complications, and long-term follow-up.
Management of splenic enlargement due to sarcoidosis consists of primarily medical therapy with prednisone, methotrexate or antimalarial drugs. Splenectomy is the last resort because of the concern about complications of surgery. This study was conducted to explore indications for splenectomy in sarcoidosis and to assess if complications associated with splenic removal were unacceptable. 13 sarcoidosis patients had their spleens removed for one or more of the following four reasons: (1) Massive splenomegaly; (2) Severe hypersplenism; (3) Need for excluding lymphoma or malignancy; and (4) Precaution against splenic rupture. All patients received strict prophylactic protocol and were followed over a period ranging from 1 to 30 years. In this long term follow-up study none of the thirteen patients developed serious infections or sepsis. No deaths occurred that might be related to splenectomy.
- 1 March 2002
- Vol. 19 (1) , 66-70
Splenectomy in sarcoidosis: indications, complications, and long-term follow-up.
Management of splenic enlargement due to sarcoidosis consists of primarily medical therapy with prednisone, methotrexate or antimalarial drugs. Splenectomy is the last resort because of the concern about complications of surgery. This study was conducted to explore indications for splenectomy in sarcoidosis and to assess if complications associated with splenic removal were unacceptable. 13 sarcoidosis patients had their spleens removed for one or more of the following four reasons: (1) Massive splenomegaly; (2) Severe hypersplenism; (3) Need for excluding lymphoma or malignancy; and (4) Precaution against splenic rupture. All patients received strict prophylactic protocol and were followed over a period ranging from 1 to 30 years. In this long term follow-up study none of the thirteen patients developed serious infections or sepsis. No deaths occurred that might be related to splenectomy.
- 1 January 2002
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 23 (6) , 579-588
Sarcoidosis of the Thyroid and Kidneys and Calcium Metabolism
In sarcoidosis, the thyroid and the kidneys are infrequently affected. Clinically recognizable thyroid involvement occurs in < 1% of sarcoidosis patients. Hyperthyroidism, myxodema, and thyroid occur with an equal frequency. It is important to distinguish sarcoidosis of the thyroid from other infections and disorders of the gland. Renal involvement may present as granulomatous infiltration of the renal parenchyma, glomerulonephritis, renal arteritis, and nephrocalcinosis or renal stones. The latter are due to abnormalities of calcium metabolism. Hypercalcemia occurs in about 10 to 13% of sarcoidosis patients; hypercalciuria is three times more frequent. Calcium abnormalities may precede, follow, or occur at any time during the course of sarcoidosis. An endogenous overproduction of 1,25-dihydroxyvitamin D [1,25-(OH2)-D3] by granulomatous tissue and activated macrophages results in an increase of intestinal absorption of calcium. Corticosteriods, chloroquine, and hydroxychloroquine subdue 1,25-(OH2)-D3 production and correct hypercalcemia and hypercalciuria.
- 1 January 2002
- Published by Georg Thieme Verlag KG in Seminars in Respiratory and Critical Care Medicine
- Vol. 23 (6) , 579-588
Sarcoidosis of the Thyroid and Kidneys and Calcium Metabolism
In sarcoidosis, the thyroid and the kidneys are infrequently affected. Clinically recognizable thyroid involvement occurs in < 1% of sarcoidosis patients. Hyperthyroidism, myxodema, and thyroid occur with an equal frequency. It is important to distinguish sarcoidosis of the thyroid from other infections and disorders of the gland. Renal involvement may present as granulomatous infiltration of the renal parenchyma, glomerulonephritis, renal arteritis, and nephrocalcinosis or renal stones. The latter are due to abnormalities of calcium metabolism. Hypercalcemia occurs in about 10 to 13% of sarcoidosis patients; hypercalciuria is three times more frequent. Calcium abnormalities may precede, follow, or occur at any time during the course of sarcoidosis. An endogenous overproduction of 1,25-dihydroxyvitamin D [1,25-(OH2)-D3] by granulomatous tissue and activated macrophages results in an increase of intestinal absorption of calcium. Corticosteriods, chloroquine, and hydroxychloroquine subdue 1,25-(OH2)-D3 production and correct hypercalcemia and hypercalciuria.
- 1 September 2001
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 7 (5) , 291-294
Unusual systemic disorders associated with interstitial lung disease
Interstitial lung disease often starts as a reaction to a causative insult or antigen, such as an inhaled environmental organic or inorganic dust and autoimmune mediated injury. When no underlying cause can be found, the inflammatory change in the gas exchanging parts of the lungs and associated fibrosis is called idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis). The common causes of pulmonary fibrosis can be classified as granulomatosus, nongranulomatous, neoplastic, and iatrogenic. There are other multisystem disorders not included in this classification that are associated with interstitial lung disease. Amyloidosis, Behcet disease, Kikuchi disease, and Whipple disease are such multiorgan disorders that involve the lungs.
- 1 September 2001
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 7 (5) , 291-294
Unusual systemic disorders associated with interstitial lung disease
Interstitial lung disease often starts as a reaction to a causative insult or antigen, such as an inhaled environmental organic or inorganic dust and autoimmune mediated injury. When no underlying cause can be found, the inflammatory change in the gas exchanging parts of the lungs and associated fibrosis is called idiopathic pulmonary fibrosis (cryptogenic fibrosing alveolitis). The common causes of pulmonary fibrosis can be classified as granulomatosus, nongranulomatous, neoplastic, and iatrogenic. There are other multisystem disorders not included in this classification that are associated with interstitial lung disease. Amyloidosis, Behcet disease, Kikuchi disease, and Whipple disease are such multiorgan disorders that involve the lungs.
- 1 September 2000
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 6 (5) , 397-398
Interferons and interstitial lung disease
- 1 September 2000
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 6 (5) , 397-398
Interferons and interstitial lung disease
- 1 September 2000
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 6 (5) , 442-447
Hypercalcemia in granulomatous disorders: a clinical review
Hypercalcemia occurs in most granulomatous disorders. High serum calcium levels are seen in about 10% of patients with sarcoidosis; hypercalciuria is about three times more frequent. Tuberculosis, fungal granulomas, berylliosis, and lymphomas are other conditions that are associated with disorders of calcium metabolism. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH2)D3 (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroquine, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.
- 1 September 2000
- Published by Wolters Kluwer Health in Current Opinion in Pulmonary Medicine
- Vol. 6 (5) , 442-447
Hypercalcemia in granulomatous disorders: a clinical review
Hypercalcemia occurs in most granulomatous disorders. High serum calcium levels are seen in about 10% of patients with sarcoidosis; hypercalciuria is about three times more frequent. Tuberculosis, fungal granulomas, berylliosis, and lymphomas are other conditions that are associated with disorders of calcium metabolism. These abnormalities of calcium metabolism are due to dysregulated production of 1,25-(OH2)D3 (calcitriol) by activated macrophages trapped in pulmonary alveoli and granulomatous inflammation. Undetected hypercalcemia and hypercalciuria can cause nephrocalcinosis, renal stones, and renal failure. Corticosteroids cause prompt reversal of the metabolic defect. Chloroquine, hydroxychloroquine, and ketoconazole are the drugs that should be used if the patient fails to respond or develops dangerous side effects to corticosteroid therapy.